Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Effect of the CCND1 A870G polymorphism on prostate cancer risk: a meta-analysis of 3,820 cases and 3,825 controls.

World journal of surgical oncology - 15 Feb 2015

Zheng Min, Wan Lijun, He Xiang, Qi Xiaolong, Liu Feng, Zhang Da-Hong

Abstract excerpt

BACKGROUND: Cyclin D1 (CCND1) is critical in the transition of the cell cycle from the G1 to S phases, and unbalanced cell cycle regulation is a hallmark of carcinogenesis. Numerous epidemiological studies have evaluated the association between the CCND1 A870G polymorphism and the risk of prostate cancer (PCa). However, these studies have yielded conflicting results. METHODS: In the present study, the possible...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Case-Control Studies
Share to Cyclin D1

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to CCND1 gene

Share to Genetic Predisposition to Disease

Share to Polymorphism, Genetic

Share to Prognosis

Share to Prostatic Neoplasms

Share to Risk Factors

Source

Open in PubMed Open full text

Identifiers

PMID: 25888980
DOI: 10.1186/s12957-015-0479-8
PMCID: PMC4344796

Genes

CCND1

Variants

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Effect of the CCND1 A870G polymorphism on prostate cancer risk: a meta-analysis of 3,820 cases and 3,825 controls.PMID 25888980Read ↗

Cyclin D1 gene polymorphism and familial prostate cancer: the AA genotype of A870G polymorphism is associated with prostate cancer risk in men aged 70 years or older and metastatic stage.Semantic proximity Read ↗

Cyclin D1 Pro241Pro (CCND1-G870A) polymorphism is associated with increased cancer risk in human populations: a meta-analysis.Semantic proximity Read ↗

Cyclin D1 G870A polymorphism and breast cancer risk: a meta-analysis comprising 9,911 cases and 11,171 controls.Semantic proximity Read ↗

Increased risk of prostate cancer associated with AA genotype of cyclin D1 gene A870G polymorphism.Semantic proximity Read ↗

The association between CCND1 G870A polymorphism and colorectal cancer risk: A meta-analysis.Semantic proximity Read ↗

Specific CCND1 G870A alleles associated with breast cancer susceptibility: a meta-analysis of 5,528 cases and 5,353 controls.Semantic proximity Read ↗

Cyclin D1 G870A polymorphism and risk of nasopharyngeal carcinoma: a case-control study and meta-analysis.Semantic proximity Read ↗

CCND1 G870A polymorphism contributes to breast cancer susceptibility: a meta-analysis.Semantic proximity Read ↗

Cyclin D1 (CCND1) G870A polymorphisms and cervical cancer susceptibility: a meta-analysis based on ten case-control studies.Semantic proximity Read ↗

The CCND1 G870A polymorphism and susceptibility to bladder cancer.Semantic proximity Read ↗

Association between cyclin D1 (CCND1) G870A polymorphism and gastric cancer risk: a meta-analysis.Semantic proximity Read ↗

Cyclin D1 G870A polymorphism contributes to colorectal cancer susceptibility: evidence from a systematic review of 22 case-control studies.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.